DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin β1 as a Molecular Target

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Structural insights into integrin α5β1 opening by fibronectin ligand

(2021) Stephanie Schumacher et al.   Science Advances

Emerging therapeutic opportunities for integrin inhibitors

(2021) R. J. Slack et al.   NATURE REVIEWS DRUG DISCOVERY

A comparative analysis of cell surface targeting aptamers

(2021) Linsley Kelly et al.   Nature Communications

The HDOCK server for integrated protein–protein docking

(2020) Yumeng Yan et al.   Nature Protocols

Aptameric Probe Specifically Binding Protein Heterodimer Rather Than Monomers

(2019) Tao Bing et al.   Advanced Science

Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding

(2019) Xiaoqiu Wu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy

(2019) Nataly Kacherovsky et al.   Nature Biomedical Engineering

Perspective on the Future Role of Aptamers in Analytical Chemistry

(2019) Yao Wu et al.   ANALYTICAL CHEMISTRY

Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus

(2018) David H. Ilson et al.   GASTROENTEROLOGY

Aptamer-based targeted therapy

(2018) Guizhi Zhu et al.   ADVANCED DRUG DELIVERY REVIEWS

Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology

(2017) Liqin Zhang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Oesophageal cancer

(2017) Jesper Lagergren et al.   LANCET

Addressing recent docking challenges: A hybrid strategy to integrate template-based and free protein-protein docking

(2017) Yumeng Yan et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Metastatic cancer cell and tissue-specific fluorescence imaging using a new DNA aptamer developed by Cell-SELEX

(2017) Baoyin Yuan et al.   TALANTA

Oesophageal cancer

(2017) Elizabeth C. Smyth et al.   Nature Reviews Disease Primers

Mechanistic basis for the recognition of laminin-511 by α6β1 integrin

(2017) Mamoru Takizawa et al.   Science Advances

Analysis of aptamer discovery and technology

(2017) Matthew R. Dunn et al.   Nature Reviews Chemistry

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) F. Lordick et al.   ANNALS OF ONCOLOGY

Aptamers as targeted therapeutics: current potential and challenges

(2016) Jiehua Zhou et al.   NATURE REVIEWS DRUG DISCOVERY

Nucleic acid aptamers in cancer research, diagnosis and therapy

(2015) Haitao Ma et al.   CHEMICAL SOCIETY REVIEWS

Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy

(2015) Xu Wu et al.   Theranostics

Esophageal Carcinoma

(2014) Anil K. Rustgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A knowledge-based scoring function for protein-RNA interactions derived from a statistical mechanics-based iterative method

(2014) Sheng-You Huang et al.   NUCLEIC ACIDS RESEARCH

Integrin Expression in Esophageal Squamous Cell Carcinoma: Loss of the Physiological Integrin Expression Pattern Correlates with Disease Progression

(2014) Christian Vay et al.   PLoS One

 1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

(2013) A. Jahangiri et al.   CANCER RESEARCH

Nucleic Acid and Peptide Aptamers: Fundamentals and Bioanalytical Aspects

(2011) Marco Mascini et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence

(2011) D. Barkan et al.   CLINICAL CANCER RESEARCH

Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach

(2009) Xiaohong Fang et al.   ACCOUNTS OF CHEMICAL RESEARCH

Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells

(2008) Dihua Shangguan et al.   JOURNAL OF PROTEOME RESEARCH